Abstract
Summary We reported a case of a 38-year-old woman with systemic vasculitis and mixed cryoglobulinemia in a context of auto-immune disease (Gougerot-Sjogren syndrome) and lymphoma. Different therapeutic strategies, including rituximab, have been proposed in order to control the effect of the systemic vasculitis and evolution of lymphoma. Rituximab is a monoclonal antibody directed against the CD20 molecule on B cells. We discuss the possible side effects of rituximab in this case of mixed cryoglobulinemia vasculitis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
